Advisors Asset Management Inc. bought a new stake in CVS Health Corporation (NYSE:CVS – Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 172,564 shares of the pharmacy operator’s stock, valued at approximately $14,787,000.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Kilter Group LLC acquired a new stake in CVS Health in the 2nd quarter valued at $27,000. J.Safra Asset Management Corp purchased a new position in CVS Health in the second quarter valued at about $30,000. Beaird Harris Wealth Management LLC raised its position in CVS Health by 201.0% in the second quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator’s stock valued at $30,000 after purchasing an additional 195 shares during the period. Timbuktu Capital Management LLC acquired a new position in shares of CVS Health during the second quarter worth about $31,000. Finally, Dunhill Financial LLC acquired a new position in shares of CVS Health during the second quarter worth about $32,000. Institutional investors and hedge funds own 80.66% of the company’s stock.
CVS Health Stock Performance
CVS Health stock opened at $80.83 on Friday. CVS Health Corporation has a 12-month low of $69.51 and a 12-month high of $110.68. The company has a market capitalization of $103.42 billion, a price-to-earnings ratio of 9.41, a price-to-earnings-growth ratio of 0.77 and a beta of 0.58. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.66. The firm’s fifty day moving average price is $88.42 and its 200 day moving average price is $89.29.
CVS Health (NYSE:CVS – Get Free Report) last issued its quarterly earnings data on Wednesday, November 4th. The pharmacy operator reported $2.09 EPS for the quarter, topping analysts’ consensus estimates of $1.65 by $0.44. The firm had revenue of $108.40 billion for the quarter, compared to analyst estimates of $104.72 billion. CVS Health had a net margin of 2.62% and a return on equity of 13.65%. The firm’s revenue was up 5.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.60 EPS. On average, research analysts forecast that CVS Health Corporation will post 8.26 EPS for the current fiscal year.
CVS Health Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Monday, November 2nd. Stockholders of record on Thursday, October 22nd were given a dividend of $0.6650 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.3%. The ex-dividend date of this dividend was Thursday, October 22nd. CVS Health’s payout ratio is presently 30.97%.
Insider Activity
In other CVS Health news, EVP Prem Shah purchased 23,855 shares of the business’s stock in a transaction that occurred on Friday, November 6th. The shares were acquired at an average price of $83.89 per share, for a total transaction of $2,001,195.95. Following the completion of the purchase, the executive vice president owned 88,516 shares in the company, valued at $7,425,607.24. The trade was a 36.89% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.85% of the company’s stock.
More CVS Health News
Investors following CVS have been watching these news items:
- Positive Sentiment: CVS ranked ninth on a recent “affordable blue chip stocks” list, which may reinforce its value-stock appeal, but the ranking itself is not a fundamental change to the business. Article: Why CVS Health cracked the Best Affordable Blue Chip Stocks list
- Neutral Sentiment: Aetna launched a five-year maternal and infant-care initiative, targeting access to essential care for 90% of members by 2032. It may support member engagement over time, but the announcement offers no clear near-term earnings impact. Article: Aetna For You & Baby initiative
- Negative Sentiment: Renewed momentum for “Medicare for All” was cited as a factor weighing on health-insurer stocks. The prospect of major changes to private insurance could create sector-wide uncertainty for CVS and its Aetna business. Article: Medicare For All momentum sinks health insurer stocks
Wall Street Analyst Weigh In
Several equities research analysts have recently weighed in on the company. Leerink Partners decreased their target price on CVS Health from $112.00 to $104.00 and set an “outperform” rating for the company in a research report on Thursday, November 5th. Royal Bank Of Canada dropped their target price on CVS Health from $113.00 to $108.00 and set an “outperform” rating on the stock in a report on Monday, November 16th. Argus boosted their price target on CVS Health from $104.00 to $114.00 and gave the stock a “buy” rating in a research report on Wednesday, August 19th. Wall Street Zen lowered CVS Health from a “strong-buy” rating to a “buy” rating in a research report on Monday, October 19th. Finally, Barclays decreased their price target on CVS Health from $108.00 to $107.00 and set an “overweight” rating for the company in a report on Thursday, November 5th. Twenty-three research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, CVS Health currently has an average rating of “Moderate Buy” and a consensus price target of $107.33.
View Our Latest Research Report on CVS Health
CVS Health Company Profile
CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division. The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.
Featured Stories
- Five stocks we like better than CVS Health
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
- Lazard’s New ETF Targets Monthly Income With Junk Bonds
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS – Free Report).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.
